Clinical Trials Directory

Trials / Completed

CompletedNCT06711237

Resin-Cement Type Influence on Cement Remnants in Implant-Supported Restorations

Comparison of Two Different Excess Cement Clean-up Options for Cementing Metal-free Ceramic Restorations on Dental Implants

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Vilniaus Implantologijos Centro (VIC) Klinika · Network
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This study quantitatively compared cement residues of two resin cement types around implant-supported restorations (ISR) with a crown-abutment margin located at the gingival level. This prospective, single-blinded, cross-over clinical trial compared optically detectable cement remnants between Self-Adhesive Resin Cement (RC) and Resin-Modified Glass Ionomer Cement (RMGIC).

Detailed description

This prospective, two-arm, non-randomized, clinical trial compared detectable cement remnants on 30 patients and 60 ISR. Two cements were compared; self-adhesive resin (RC) and resin-modified glass ionomer (RMGIC). Comparisons were carried out on identical pairs of ISR tested within the same patients with a 1-week healing interval. The primary outcome variable was the ratio of cement-covered area to total crown area. Areas were analyzed ex-situ by standardized digital image analysis.

Conditions

Interventions

TypeNameDescription
OTHERself-adhesive resin cement (RC)Single-unit implant-supported single crowns were cemented to the abutments using a self-adhesive resin cement (RC). Residual cement was removed, and the restorations were retrieved for analysis of cement remnants.
OTHERresin-modified glass-ionomer cement (RMGIC)Single-unit implant-supported single crowns were cemented to the abutments using a resin-modified glass-ionomer cement (RMGIC). Residual cement was removed, and the restorations were retrieved for analysis of cement remnants.

Timeline

Start date
2021-09-01
Primary completion
2022-03-01
Completion
2022-09-01
First posted
2024-12-02
Last updated
2024-12-02

Locations

1 site across 1 country: Lithuania

Source: ClinicalTrials.gov record NCT06711237. Inclusion in this directory is not an endorsement.